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Abstract
Pulmonary involvement and skin involvement are rare complications of plasma cell neoplasms.
Here we describe what may be the first reported case of a patient with relapse in both of these
sites following autologous peripheral blood stem cell transplantation.
Text
We report a 58-year-old man with diffuse pulmonary
parenchymal plasma cell infiltration and skin nodules.
Five years previously he had been treated successfully with
VAD (vincristine, adriamycin and dexamethasone) chem-
otherapy and an autologous peripheral blood stem cell
transplant for multiple myeloma. Four years later he
relapsed with anemia, hypercalcemia, and an IgG of 6170
mg/dl. Skeletal survey showed no lytic lesions, the mar-
row was 30% infiltrated by plasma cells with a
t(11;14)(q13;q32) and a del 13q14.3 abnormality. The
paraprotein level transiently responded to thalidomide-
dexamethasone, but he in turn developed hyperammone-
mia, which responded to the addition of bortezomib and
liposomal pegylated doxorubicin to the regimen.
During the 3rd cycle of this regimen, subcutaneous nod-
ules appeared on all four extremities, and a needle aspi-
rate revealed plasma cells (figure 1A, B). The WBC rose to
> 40,000/cmm with 50% circulating plasma cells. He
developed dyspnea and cough, and CT revealed peri-
bronchial thickening and patchy opacities diffusely (fig-
ure 1C). Bronchoalveolar lavage (BAL) demonstrated
kappa restricted plasma cells (Figure 1D, E). He soon after
expired, concurrent with a rise in the ammonia level.
Discussion
In plasma cell neoplasms, pulmonary complications are
common, but infection is the most common cause. In a
series of 958 patients with myeloma, 10% had pulmonary
findings, but in only 1 case was plasma cell involvement
demonstrated histologically, and the clinical course was
suggestive of plasma cell involvement in only 3 other
cases [1]. In the literature, there are additional cases of
pulmonary involvement: some of these had advanced or
treatment-refractory disease, like our patient [2-4],
whereas in several cases, the lung was the initial site of
presentation [5-8]. Likewise, skin involvement is rare, but
this too has been reported [9,10]. We believe that this is
the first case patient reported to have both sites of involve-
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ment as a complication of relapsed disease after autolo-
gous stem cell transplantation. The presence of circulating
plasma cells and hyperammonemia are both known to be
indicators of advanced disease. Plasma cell neoplasm
should be kept in the differential diagnosis of any pulmo-
nary infiltrate not responding to antibiotics or as a possi-
ble cause of skin nodules in a patient with a history of
myeloma, plasmacytoma, or MGUS.
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(A) Skin nodules; (B) Wright Giemsa stain, aspirate of skin nodules; (C) Chest CT showing diffuse infiltrates; (D) H&E of BAL;  (E) Kappa staining of BAL Figure 1
(A) Skin nodules; (B) Wright Giemsa stain, aspirate of skin nodules; (C) Chest CT showing diffuse infiltrates; 
(D) H&E of BAL; (E) Kappa staining of BAL.
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